FDA Public Meeting Archives - NORD (National Organization for Rare Disorders)

Public Meeting on Patient-Focused Drug Development for Chronic Pain

Written by Christina Jensen on July 9, 2018

On July 9, 2018, FDA is hosting a public meeting on Patient-Focused Drug Development for Chronic Pain. FDA is interested in hearing patients’ perspectives on chronic pain, views on treatment approaches, and challenges or barriers to accessing treatments for chronic pain. FDA is particularly interested in hearing from patients who… Read More

NORD Issues Statement in Response to PDUFA VI Commitment Letter

Written by Paul Melmeyer on July 21, 2016

On July 15, the Food and Drug Administration released the performance goals letter for the reauthorization of the Prescription Drug User Fee Act, also known as PDUFA VI. The PDUFA program is the agreement between the FDA and the pharmaceutical industry to pay user fees to facilitate the… Read More

Archives for: July 9th, 2018

Public Meeting on Patient-Focused Drug Development for Chronic Pain

Written by Christina Jensen on July 9, 2018

NORD Issues Statement in Response to PDUFA VI Commitment Letter

Written by Paul Melmeyer on July 21, 2016

Alone we are rare. Together we are strong.®